Rocket Pharmaceuticals Files 8-K for Financials
Ticker: RCKTW · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Rocket Pharma dropped an 8-K on Feb 27th - check it for financial updates.
AI Summary
Rocket Pharmaceuticals, Inc. filed an 8-K on February 27, 2025, to report on its results of operations and financial condition, and to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing signals that Rocket Pharmaceuticals is providing updated financial information and operational details to the public, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for financial reporting and does not contain any immediately apparent negative or positive material events.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- February 27, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36829 (identifier) — SEC File Number
- 9 Cedarbrook Drive, Cranbury, NJ 08512 (address) — Principal Executive Offices
- 646-440-9100 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing indicates it is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not include the specific financial figures or operational details within this excerpt.
When was this 8-K filing submitted by Rocket Pharmaceuticals, Inc.?
The filing was submitted on February 27, 2025.
What is the principal executive office address for Rocket Pharmaceuticals, Inc.?
The principal executive offices are located at 9 Cedarbrook Drive, Cranbury, NJ 08512.
What is the SEC file number for Rocket Pharmaceuticals, Inc.?
The SEC file number for Rocket Pharmaceuticals, Inc. is 001-36829.
What is the SIC code for Rocket Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Rocket Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).